• Home
  • About us
  • Log-In
  • Join Us
  • Sitemap
  • Recruit
Á¦Ç°/½ÇÇè Q&A
ÀÚÁÖ¹¯´ÂÁú¹®
ÀÚÀ¯°Ô½ÃÆÇ
½ÇÇè±â¹ý
ÀÚ·á½Åû
³í¹®ÀÚ·á
Ŭ·¹ÀÓ Á¢¼ö
±â±â A/S Á¢¼ö
Ŭ·¹ÀÓ ÁøÇàÁ¶È¸
 Á¦Ç°¾È³»  ºÐ¼® Á¦ÀÛ ¼­ºñ½º   Virus Á¦ÀÛ ¼­ºñ½º

AAV Á¦ÀÛ¼­ºñ½º

³·Àº Immunogenicity·Î in vivo ½ÇÇè¿¡ ÃÖÀûÈ­µÈ AAV¸¦ Á¦ÀÛÇØ µå¸³´Ï´Ù.

Sirion Biotech
Á¦Ç° ¹®ÀÇÇϱâ
ÀμâÇϱâ

Á¦ÀÛ ¼­ºñ½º °ßÀû¿äû

  • In vivo¿¡¼­ long term gene expression È®Àο¡ ÀûÇÕÇÑ AAV¸¦ Á¦ÀÛÇØ µå¸³´Ï´Ù.
  • ÃÖÀûÀÇ AAVÁ¦ÀÛÀ» À§ÇÑ °í°´¸ÂÃã ÄÁ¼³ÆÃÀ» Á¦°øÇÕ´Ï´Ù.
  • Target cell/tissue¿¡ µû¶ó ÀûÇÕÇÑ serotype/ promoter¸¦ ÃßÃµÇØ µå¸³´Ï´Ù. (serotype 1-9, 1/2 hybrid)
  • °í¼øµµÀÇ AAV particleÀ» Á¦°øÇÕ´Ï´Ù.
  • ¸ñÀû¿¡ µû¶ó 2-Step Á¤Á¦¸¦ °ÅÄ£ ÃÊ°í¼øµµ AAV particleÀ» ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
  • Á¦À۱Ⱓ : (Á¦ÀÛ scale¿¡ µû¶ó) 3-7ÁÖ
 


 ¼­ºñ½º ³»¿ë ¸ñÀû
 AAV generation  CloningºÎÅÍ AAV particle »ý»ê, 1-step Á¤Á¦ ¹× ³óÃà, QC  ÀϹÝÀûÀÎ R&D (in vitro/in vivo) 
CloningºÎÅÍ AAV particle »ý»ê, 2-step Á¤Á¦ ¹× ³óÃà, QC  ÀüÀÓ»ó ¿¬±¸ÀÇ in vivo application 
 AAV Cloning Á¦°øÇϽŠcDNA ȤÀº À¯ÀüÀÚ Á¤º¸·Î AAV plasmid vector Ŭ·Î´×  -